Independent guide•Purchases are completed on the partner merchant’s website
In-depth ingredient profile

InnoSlim: effects, studies, dose and real relevance to PhenQ

InnoSlim deserves separate analysis because it is a proprietary blend, not simply “ginseng”. Human research exists on a standardized astragalus and notoginseng extract, but the evidence remains limited and does not prove substantial weight loss.

Patented Astragalus membranaceus + Panax notoginseng blendPresent in PhenQCritical reading of the evidence
Q
Qenph evidence review

Manufacturer sources are separated from studies and institutional references. Conclusions concern the level of evidence, not a commercial promise.

Biological roleTo distinguish from clinical effectiveness
Human studiesAnalyzed by dose and population
Complete productNot inferred from an isolated ingredient

What is InnoSlim?

InnoSlim is a standardized blend of Astragalus membranaceus and Panax notoginseng root extracts developed by NuLiv Science. Published research mainly focuses on glucose and lipid metabolism markers and on adiponectin/AMPK pathways.

Why is this ingredient present in PhenQ?

The brand includes it in PhenQ to support claims about glucose metabolism and fat use. This is a typical example where three things must be separated: cellular mechanisms, changes in blood markers and weight loss actually measured.

E-E-A-T point: a physiological function or plausible mechanism does not prove that a finished product causes measurable weight loss. Qenph deliberately separates mechanism, study outcome and effectiveness of the complete product.

What the studies really say

Here are the most useful points for assessing this ingredient without turning scientific data into an advertising slogan.

Small human trial

A randomized, double-blind crossover trial studied a standardized extract in adults with elevated blood glucose and lipids. Only nine participants were included in the final analysis.

Reading level: Very small sample

Metabolic markers

After six weeks, several glycemic and lipid markers improved compared with placebo in this small study. The authors also reported changes in adiponectin and AMPK.

Reading level: Interesting signal

Body weight

Key point: the same publication states that no significant anthropometric difference was observed after six weeks for weight, BMI, waist circumference or fat mass.

Reading level: No evidence of weight loss in this trial

Why dose completely changes interpretation

In the published trial on metabolic markers, participants took five capsules per day, each containing 50 mg of a standardized blend, or 250 mg/day. This does not mean PhenQ necessarily provides the same amount or that the two uses are directly comparable.

To compare a study properly with a supplement, you need at least the daily amount, chemical form or extract, any standardization and duration of use. If any of these are missing, conclusions should remain cautious.

Tolerance, precautions and interactions

The pilot study found no significant change in liver or kidney markers over six weeks. Toxicology work on the blend also exists. These findings are reassuring but do not replace long-term, large and independent safety data across all populations.

Caution: pregnancy, breastfeeding, chronic illness, regular medication or combining several supplements are reasons to seek advice from a doctor or pharmacist. This profile does not replace an individual assessment.

What Qenph concludes

Evidence verdict: InnoSlim has more specific data than many marketing blends, but the most readily verifiable published human trial is tiny and showed no significant anthropometric change at six weeks. Improvements in metabolic markers should therefore not be presented as direct evidence of weight loss.

What to check before buying

  • the exact daily dose of InnoSlim;
  • the form or extract used;
  • the presence of other stimulants, minerals or amino acids that may add up;
  • the manufacturer’s warnings;
  • the difference between claimed effects and results actually measured in trials.

Frequently asked questions

Does InnoSlim cause weight loss on its own?

The available data do not support presenting InnoSlim as a stand-alone weight-loss solution. Even when an effect is observed in trials, its magnitude is generally modest or depends on a specific dose and population.

Can studies on InnoSlim be applied directly to PhenQ?

No. The ingredient form, daily dose, duration of use and population need to be comparable. A positive study on an isolated ingredient does not automatically validate a multi-ingredient formula.

Why does Qenph emphasize dose so much?

Because an ingredient may be present in too small an amount to reproduce effects seen in a study. Simply appearing in an ingredient list is not enough to conclude clinical effectiveness.

View the product

InnoSlim is present in PhenQ

See the Qenph product profile to place this ingredient in the context of the complete formula, then check the current offer and label with the merchant.

How Qenph verifies its content:MethodologySourcesEditorial policyCorrections